Related Experiment Video
Updated: Jul 17, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
3-methylcrotonyl-CoA carboxylase deficiency and severe multiple sclerosis
Niklas Darin1, Oluf Andersen, Lars-Martin Wiklund
1Department of Pediatrics, Sahlgrenska University Hospital, Göteborg, Sweden. niklas.darin@vgregion.se
Abstract:
This report describes a female with isolated 3-methylcrotonyl-CoA carboxylase deficiency. She had a mild Reye-like episode, loss of scalp hair, psychomotor retardation, and an attention-deficit hyperactivity disorder. The diagnosis was made at 13 years of age when she developed relapsing remitting multiple sclerosis with a malignant course. Treatment with steroids had initially a good therapeutic effect on the relapses. The response to interferon beta-1a treatment was poor. On mitoxantrone treatment there was a considerable neurologic recovery.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
